Mayer-Rokitansky-Küster-Hauser syndrome: causes, symptoms, diagnosis, and treatment

Mayer-Rokitansky-Küster-Hauser syndrome is a congenital condition in which a person with a 46,XX female karyotype and typically normal ovarian function has an absent or severely underdeveloped uterus and the upper two-thirds of the vagina. The external genitalia are typically developed in a female pattern, and secondary sexual characteristics, including breast development, appear at the normal time. This is why the condition often goes unnoticed until adolescence, when the absence of menstruation becomes apparent. [1]

This condition refers to congenital anomalies of the Müllerian ducts, the embryonic structures that normally form the uterus, cervix, fallopian tubes, and upper vagina. In Mayer-Rokitansky-Küster-Hauser syndrome, this stage of development is disrupted, while the ovaries typically remain functionally intact. Therefore, in most patients, female sex hormone levels remain normal, ovulation can occur, but menstrual function and pregnancy are impossible without specialized reproductive technologies. [2]

From a clinical perspective, this is one of the most important causes of primary amenorrhea. Recent reviews indicate that Mayer-Rokitansky-Küster-Hauser syndrome is the second most common cause of primary amenorrhea after ovarian insufficiency, accounting for approximately 16% of such cases. Therefore, in an adolescent with normal body type, normal sexual development, and no menarche, this diagnosis should be one of the first options. [3]

The significance of the syndrome is not limited to reproductive anatomy. Some patients simultaneously exhibit anomalies of the kidneys, spine, ears, heart, and other organs. This makes the disease not simply a localized gynecological finding, but a multisystem condition requiring careful assessment of adjacent body systems. In large cohorts, the presence of at least one associated malformation has been described in approximately 35.2% of patients, while in earlier European series, the figure was 28-44%. [4]

The psychological aspect is equally important. Diagnosis is typically made in adolescence, when issues of body identity, sexuality, and future motherhood are particularly sensitive. Recent reviews emphasize that receiving a diagnosis often causes significant stress, a sense of loss, anxiety, decreased self-esteem, and worries about infertility. Therefore, the modern standard of care includes not only anatomical and hormonal assessment but also comprehensive psychological support. [5]

Code according to ICD 10 and ICD 11

Mayer-Rokitansky-Küster-Hauser syndrome has an important coding feature: in the International Classification of Diseases, 10th revision, it usually does not have a single universal code, because the condition itself combines the absence of the uterus and upper vagina, as well as possible associated anomalies. Therefore, clinical documentation often uses a combination of codes for specific anatomical defects, primarily Q51.0 for agenesis or aplasia of the uterus and Q52.0 for congenital absence of the vagina. This approach is supported by both review publications on the syndrome and the nomenclature of the World Health Organization. [6]

In the International Classification of Diseases, 11th revision, the situation has become somewhat more convenient, since Mayer-Rokitansky-Küster-Hauser syndrome is explicitly listed as a synonym for code LB44.Y, "other specified structural malformations of uterus, except cervix." However, even with this, a full reflection of the anatomy typically requires additional coding for the absence of the vagina with code LB42.0, and in the presence of renal, skeletal, or cardiac defects, additional corresponding accompanying codes. In other words, the modern system allows for the syndrome itself to be specified as a nosological entity, but the anatomical completeness of the diagnosis still needs to be clarified with additional codes. [7]

Clinical situation	International Classification of Diseases, 10th revision	International Classification of Diseases, 11th revision	Comment
Classic uterine absence syndrome	Q51.0	LB44.Y	In the International Classification of Diseases, 11th revision, the syndrome is listed as a synonym
Absence of a vagina	Q52.0	LB42.0	Often encoded additionally
Syndrome as a single entry in the chart	Usually a combination of Q51.0 and Q52.0	LB44.Y with possible addition of LB42.0	The choice depends on the completeness of the anatomical description
The presence of concomitant renal or skeletal defects	Additional codes	Additional codes	They are coded separately.
Atypical or mixed forms	By main anatomical components	With cluster refinement	Require individual coding

The table is based on the Mayer-Rokitansky-Küster-Hauser syndrome overview, the International Classification of Diseases, 10th revision of the World Health Organization, and the International Classification of Diseases, 11th revision classification for uterine and vaginal anomalies. [8]

Epidemiology

Mayer-Rokitansky-Küster-Hauser syndrome is a rare disorder, but it occurs frequently enough in adolescent gynecology that every physician dealing with primary amenorrhea should keep it in mind. The most commonly cited prevalence estimate is approximately 1 case per 5,000 live births. This figure is repeated in several large reviews and supported by population-based studies from Finland and Denmark. [9]

According to the Danish national registry, the prevalence was 1 in 4,982 live-born girls, while a Finnish population study yielded a very close estimate of 1 in 4,961. This agreement across independent national samples makes the range of approximately 1 in 5,000 the most reliable practical estimate. However, the authors of the reviews emphasize that the actual incidence may differ slightly in other regions of the world, as some patients remain undiagnosed for a long time. [10]

Among all causes of primary amenorrhea, Mayer-Rokitansky-Küster-Hauser syndrome ranks among the leading causes. In review data, it accounts for approximately 16% of cases of primary amenorrhea. From a practical standpoint, this means that if a teenager with normal breasts and estrogen levels experiences no menstrual periods, the physician must consider Müllerian anomalies early on in the examination. [11]

The disease phenotype is heterogeneous. In the classic variant without extragenital malformations, that is, type 1, the condition is described in approximately 56-72% of patients. Type 2 with associated anomalies occurs in approximately 28-44% of patients according to large series, although in a modern cohort of 469 patients, the proportion of women with at least one associated malformation was 35.2%. This is important because the same primary complaint—absence of menstruation—can conceal both isolated and systemic forms of the disease. [12]

Renal anomalies are the most common among associated anomalies. In a modern cohort, renal defects were detected in 22.8% of all patients, and among patients with additional anomalies, renal changes accounted for 64.8% of this subgroup. Skeletal anomalies ranked second, occurring in 49.1% of patients with type 2, with the spine most commonly affected. These data confirm the need for a mandatory search for extragenital anomalies, even in patients with good general health. [13]

Epidemiological indicator	Meaning
Estimated prevalence	About 1 in 5,000 live-born girls
Finnish population study	1 in 4961
Danish population study	1 in 4982
The share of causes of primary amenorrhea	About 16%
Type 1	Approximately 56-72%
Type 2	Approximately 28-44%
Presence of at least 1 associated anomaly in a modern large cohort	35.2%
Renal anomalies among the entire cohort of 469 patients	22.8%

The table is based on population-based studies, a large 2024 cohort, and a contemporary review of Mayer-Rokitansky-Küster-Hauser syndrome. [14]

Reasons

The exact cause of Mayer-Rokitansky-Küster-Hauser syndrome remains unknown. Current literature describes the disease as heterogeneous, meaning it arises not through a single mechanism, but rather through the interaction of several possible pathways of embryonic developmental disruption. At the current stage of evidence, the most likely mechanism is a combination of genetic, regulatory, and environmental influences acting during the critical period of Müllerian duct formation. [15]

The underlying anatomical defect is the arrest of development or aplasia of the paramesonephric, or Müllerian, ducts. These ducts normally form the uterus, cervix, fallopian tubes, and upper vagina. If this process is interrupted early, the resulting defects range from incomplete development of uterine rudiments to the virtual absence of the uterus and upper vagina. [16]

A genetic contribution is suggested by family observations and new molecular studies. Modern genomic studies have identified recurring changes in the 17q12 and 16p11.2 loci, as well as variations in the GREB1L, PAX8, LHX1, HNF1B, and TBX6 genes. However, it is important to understand that none of these genetic findings explains all cases of the disease, so the syndrome is not considered a monogenic disorder with simple inheritance. [17]

Some researchers suggest the role of oligogenic and multifactorial mechanisms, whereby not a single mutation, but a combination of several genetic variants and external influences is crucial. Epigenetic changes and somatic events during embryogenesis are also considered. This concept explains well why the disease is often sporadic and can manifest itself very differently within a single family—from a complete syndrome to isolated renal anomalies. [18]

It should be emphasized that, to date, no specific external cause has been proven to be the primary trigger. Teratogenic effects and other intrauterine influences are discussed in the literature, but a convincing universal mechanism has not been found. Therefore, it is more accurate to speak not of a "culpable cause," but of a complex disorder of embryonic morphogenesis with a multifactorial nature. [19]

Risk factors

Familial predisposition remains the main established risk factor. Although most cases appear sporadic, accumulating data on familial recurrences and recurrent genetic variants demonstrates that a hereditary component does exist. However, inheritance, when present, is most often described as incomplete penetrance and variable expressivity, meaning that even within a single family, manifestations can vary in severity and composition of abnormalities. [20]

A family history of renal anomalies, particularly unilateral renal agenesis, may be an indirect risk factor. Variants in the GREB1L gene have been described in some families with Mayer-Rokitansky-Küster-Hauser syndrome and associated urogenital defects. This does not mean that every isolated renal anomaly in a relative predicts the syndrome, but such an association increases caution when collecting a family history. [21]

Potential risk factors also include intrauterine disturbances of early embryogenesis, particularly during the 5th to 6th week of gestation, when the Müllerian ducts are being established. However, this represents a period of vulnerability rather than a specific, manageable risk. In clinical practice, this fact is important not for retroactive preventative advice, but for understanding that the disease develops very early and is not related to the lifestyle of the adolescent or her family after birth. [22]

Puberty, stress, sports, nutrition, or delayed presentation cannot be considered risk factors. These circumstances may only influence the time of detection of the disease, but not its onset, as the syndrome is congenital. This clarification is especially important for families, who, after diagnosis, often look for "errors" in parenting, nutrition, or adolescent behavior. [23]

Thus, the list of real risk factors remains limited. The most widely supported are family history, genetic predisposition, and early embryonic developmental disorders, but universal modifiable factors comparable to smoking or obesity in other diseases have not yet been identified. This is one of the reasons why preventing the syndrome remains an unsolved problem. [24]

Pathogenesis

The pathogenesis of Mayer-Rokitansky-Küster-Hauser syndrome is associated with a disruption in the formation of the paramesonephric, or Müllerian, ducts. Normally, these ducts begin to develop around the 5th to 6th week of embryonic development, then grow caudally, merge, and form the uterus, cervix, and upper vagina. If this process is disrupted, a spectrum of anomalies develops, ranging from rudimentary uterine cords to complete absence of the uterus and upper vagina. [25]

The ovaries typically develop independently of the Müllerian ducts, so their function often remains intact. This explains the paradoxical situation for the family: the adolescent undergoes normal thelarche and pubarche, develops a typical female phenotype, but does not menstruate. From a hormonal perspective, the body may function almost normally, but there is no anatomical substrate for menstruation and pregnancy. [26]

A modern genetic model suggests that the disorder affects not a single gene, but rather networks that control organogenesis of the genitourinary system. Variants in the genes LHX1, HNF1B, GREB1L, PAX8, TBX6, and others likely interfere with signals for growth, migration, and spatial organization of tissues. The connection between renal and Müllerian defects is particularly intriguing, as these systems develop anatomically close to each other and partially share common regulatory mechanisms. [27]

Pathogenesis also helps to understand the diversity of clinical forms. If the disorder affects only the Müllerian structures, type 1 results. If the kidneys, spine, auditory apparatus, or heart are simultaneously affected, type 2 occurs, sometimes described as an association of Müllerian aplasia, renal aplasia, and cervicothoracic dysplasia. Thus, the clinical phenotype reflects the depth and breadth of the embryonic defect. [28]

In some patients, uterine rudiments persist, and sometimes a functioning endometrium is found within them. Then, the pathogenesis of symptoms changes: cyclical pelvic pain, blood accumulation in a closed cavity, and the risk of endometriosis are added to the anomaly itself. In large studies, endometrium was found in approximately 40.8% of removed rudiments, and rudiments with an endometrium were, on average, larger. [29]

Symptoms

The most typical symptom is primary amenorrhea, the absence of the first menstrual period despite normal development of secondary sexual characteristics. It is with this complaint that most patients first present to a doctor during late puberty. Current recommendations for amenorrhea recommend a mandatory examination if menarche has not occurred by age 15 or within three years of the onset of breast development. [30]

Externally, many adolescents appear completely healthy. They have normal height, a normal build, developed breasts, typical female hair growth, and normal-looking external genitalia. Therefore, the absence of menstruation often becomes the first and only noticeable signal to the family that there is a congenital anomaly within the pelvis. [31]

The second important symptom is a shortened, blind-ended vagina. In practice, this may not be a concern until sexual activity begins, but later manifests as difficulty with intercourse, pain, inability to penetrate, or a pronounced fear of it. For some patients, this problem, rather than the absence of menstruation, becomes the main reason for seeking medical attention. [32]

If uterine rudiments with a functioning endometrium are present, cyclic pelvic pain may occur. This pain may recur monthly, even though there is no visible menstruation. This is due to the fact that the endometrium in the rudimentary cavity responds to the hormonal cycle, but the blood has no outlet. In such cases, the likelihood of hematometra in the rudimentary cavity and associated endometriosis increases. [33]

Finally, in some patients, the symptoms are supplemented by manifestations of concomitant anomalies. These may include lower back pain, recurrent urinary tract infections, postural changes, scoliosis, hearing loss, or other complaints related to the specific set of extragenital malformations. Therefore, the syndrome cannot be assessed solely by the presence or absence of the uterus on ultrasound. [34]

Symptom or sign	How typical is it?	What could it mean?
Primary amenorrhea	Very typical	The main reason for the initial appeal
Normal mammary glands and hair growth	Very typical	The ovaries are normally functional
Shortened blind vagina	Often	Explains difficulties with sexual intercourse
Cyclic pelvic pain	It doesn't happen to everyone	Uterine rudiments with endometrium are possible
Infertility due to the absence of the uterus	Almost inevitable without special technologies	An absolute uterine factor of infertility is formed
Renal or skeletal complaints	For type 2	An extended search for associated anomalies is needed.

The table is based on current reviews of Mayer-Rokitansky-Küster-Hauser syndrome and recommendations for amenorrhea. [35]

Classification, forms and stages

The most commonly used clinical classification divides the syndrome into two forms. Type 1 is isolated Müllerian aplasia, when the anomaly is limited to the uterus and upper vagina. Type 2 is the syndromic form, when uterovaginal aplasia is accompanied by renal, skeletal, auditory, cardiac, or other developmental defects. This approach remains the primary one in both modern reviews and genetic publications. [36]

Within type 2, a more severe phenotype is distinguished, traditionally referred to as the association of Müllerian aplasia, renal aplasia, and cervicothoracic dysplasia. Essentially, this is an extreme variant of the syndromic form with a combination of urogenital and axial skeletal abnormalities. For the clinician, this is important not as an academic subtlety, but as a clue as to which organs require particularly careful examination. [37]

Anatomical variations based on the presence of uterine rudiments are described separately. Some patients retain two rudimentary rudiments, others retain one, and in some, uterine structures are completely absent. In a large cohort, laparoscopy confirmed the presence of rudiments in 85.5% of 310 patients undergoing surgery, with bilateral rudiments more common in type 1 than in type 2. [38]

There is no generally accepted staging system for Mayer-Rokitansky-Küster-Hauser syndrome, similar to the stages of a tumor or endometriosis. In practice, the physician describes not a "stage" but a phenotype: whether the disease is isolated or syndromic, whether there are uterine rudiments, whether there is a functioning endometrium, the length of the vaginal cul-de-sac, whether there is pain, and what extragenital anomalies are present. This approach is more useful for treatment selection than attempting to formally assign a stage. [39]

Classifications of congenital anomalies of the female reproductive tract, developed by professional societies of reproductive specialists and gynecologists, are of great importance for visualization and treatment planning. They help accurately describe which structures are absent and which are preserved, and how this relates to surgical tactics. However, in everyday practice, when speaking with patients, the most commonly used terminology is still clear: type 1, type 2, and the presence or absence of functional rudiments. [40]

Complications and consequences

The most obvious consequence is the inability to carry a pregnancy to term due to the absence of a functioning uterus. This creates absolute uterine factor infertility, which was long considered an insurmountable barrier to biological motherhood. Today, reproductive options have expanded, but without special technologies, natural pregnancy with classic infertility syndrome is impossible. [41]

If a patient has uterine rudiments with active endometrium, cyclic pelvic pain, hematometra in a closed cavity, and endometriosis are possible. Recent reviews emphasize that this group of patients most often requires laparoscopic intervention. In a large study, rudiments were removed in cases of cyclic pain, suspicion of endometriosis based on magnetic resonance imaging, or a desire for prophylactic removal after consultation. [42]

A separate group of complications are the consequences of associated malformations. Renal anomalies can increase the risk of urological problems, skeletal anomalies can lead to chronic pain, postural disorders, and limited mobility, and rare cardiac anomalies require special monitoring. This is why Mayer-Rokitansky-Küster-Hauser syndrome type 2 cannot be managed by a single gynecologist without the involvement of related specialists. [43]

Sexual and psychological consequences are significant. Without adequate treatment, a shortened vagina can cause pain, avoidance of intimacy, fear of relationships, and chronic tension. Recent reviews highlight that receiving a diagnosis is often accompanied by a diminished sense of femininity, anxiety, and emotional distress, especially when the topic of infertility is discussed without prior psychological preparation. [44]

Finally, complications are also possible after treatment. After dilation therapy, discomfort and poor compliance are possible, and after surgical formation of the neovagina, stenosis, the need for prolonged subsequent dilation, bladder or rectal injury, adhesions, and other complications depending on the technique may occur. Therefore, even a successful surgical solution is not a "one-time fix" after which no further observation is necessary. [45]

Consequence or complication	When does it occur more often?	Why is it important?
Absolute uterine factor infertility	Almost always	The Main Reproductive Challenge
Cyclic pelvic pain	With functional uterine rudiments	May indicate endometrium within the rudiment
Endometriosis	In some patients, especially those with rudiments	Maintains pain and worsens quality of life
Dyspareunia or inability to have sexual intercourse	With a short vaginal canal	Requires step-by-step treatment
Urological problems	In type 2 with renal abnormalities	Monitoring of kidneys and urinary tract is necessary.
Psychological distress	Often after diagnosis	Needs psychological help
Neovaginal stenosis and the need for maintenance dilation	After some operations	Long-term support is required

The table is based on large contemporary cohorts, the 2026 review, and recommendations from the American College of Obstetricians and Gynecologists.[46]

When to see a doctor

The first reason to consult a doctor is the absence of menstruation by age 15 despite already developed mammary glands, or the absence of menarche three years after the onset of thelarche. This does not automatically indicate the presence of Mayer-Rokitansky-Küster-Hauser syndrome, but it does require a thorough examination for the causes of primary amenorrhea. And it is within this diagnostic group that this syndrome occupies a leading position. [47]

Another clinical situation may also prompt a visit: no menstruation, but the teenager is otherwise developing normally and does not appear "endocrine-disordered." This combination often misleads families and leads to late diagnosis. Normal mammary gland development does not rule out a serious congenital anomaly of the internal reproductive tract. [48]

You should also consult a doctor if you experience difficulty with sexual intercourse, severe pain when attempting penetration, or a sensation that the vagina is too short. These complaints often appear in adulthood in patients who were not diagnosed during adolescence. Current recommendations emphasize that treatment should only begin when the patient is ready, but that diagnosis should not be delayed. [49]

A particular warning sign is cyclical lower abdominal pain without menstruation. This may indicate the presence of a functioning uterine uterus, hematometra, or endometriosis. In this situation, delaying examination is undesirable, as the symptom reflects not only an anatomical abnormality but also an active pathological process. [50]

Finally, it is worth consulting a doctor even if the diagnosis has already been established, if there is lower back pain, recurrent urinary tract infections, scoliosis, hearing loss, or other symptoms that may be associated with type 2. In Mayer-Rokitansky-Küster-Hauser syndrome, the primary gynecological problem often becomes the entrance to the detection of other congenital anomalies that previously remained undetected. [51]

Diagnostics

Diagnosis begins with a proper assessment of primary amenorrhea. The physician determines the age of onset of thelarche, the presence of cyclic pain, family history, and the characteristics of the urinary system and spine, followed by a careful examination of the external genitalia and vaginal opening. Even at this stage, a short, blind-ended vagina may be detected, which directs further investigation. [52]

The next step is visualization of the pelvic organs. Transabdominal or transperineal ultrasound can detect the absence of the uterus and visualize the ovaries. However, ultrasound does not always provide definitive anatomical clarity, especially in young patients, with atypical organ positions, or with the presence of small rudiments. Therefore, if there is any doubt, the examination should be continued rather than stopped at one conclusion. [53]

Magnetic resonance imaging is now considered a key method for accurate anatomical assessment. Modern reviews cite it as the basis for detailed analysis, and an earlier fundamental review explicitly defines it as the gold standard for diagnosing uterine agenesis, especially when the method is available. Magnetic resonance imaging helps confirm the diagnosis, visualize uterine rudiments, determine the presence of endometrial tissue within them, assess the length of the vaginal canal, and simultaneously examine the kidneys and other pelvic structures. [54]

Laboratory diagnostics are needed not to confirm the anomaly itself, but to properly differentiate it. Gonadotropins, estradiol, androgen status, and karyotype are typically assessed. In Mayer-Rokitansky-Küster-Hauser syndrome, normal female hormone levels and a 46,XX karyotype are expected, which helps differentiate it from complete androgen insensitivity and other disorders of sexual development. [55]

Once the diagnosis is confirmed, associated anomalies are always examined. At a minimum, the kidneys are assessed, and if necessary, the spine, hearing, and heart are also examined. A modern review from 2026 emphasizes that renal and skeletal anomalies are often asymptomatic, so they should not be sought solely in the presence of complaints. This is one reason why a correct diagnosis always initiates a broader examination than simply a pelvic magnetic resonance imaging (MRI). [56]

Laparoscopy is becoming less and less necessary for diagnosis. Recent reviews emphasize that, with the availability of high-quality magnetic resonance imaging, it is rarely required for diagnosis alone, but can be useful if the patient has painful uterine rudiments and their removal is planned. This reflects a general shift in modern medicine toward less invasive diagnostics. [57]

Diagnostic step	What is being assessed?	What does this give?
Anamnesis	Age, primary amenorrhea, pain, family history, urological complaints	Forms a correct diagnostic hypothesis
Inspection	External genitalia, vaginal entrance, its depth	Allows you to see the short blind vagina
Ultrasound examination	Uterus, ovaries, and pelvic anatomy	Primary visualization method
Magnetic resonance imaging	Uterine rudiments, endometrium, vaginal canal, kidneys, organ relationships	The most accurate anatomical assessment
Hormonal profile	Gonadotropins, estradiol, androgens	Helps differentiate from endocrine causes of amenorrhea
Karyotype	46,XX or another option	Key to differential diagnosis
Examination of the kidneys and spine	Renal and skeletal defects	Mandatory search for associated anomalies
Laparoscopy	According to the readings	Used primarily for pain and surgical planning

The table is based on the 2020 review, 2026 review and amenorrhea recommendations. [58]

Differential diagnosis

The main clinical question in primary amenorrhea and apparent absence of the uterus is whether it is truly Mayer-Rokitansky-Küster-Hauser syndrome, rather than another condition with a similar appearance. The most important mistake to avoid is confusing it with complete androgen insensitivity. In both cases, the uterus may be absent and the vagina may be short, but in complete androgen insensitivity, the karyotype is 46,XY, and testosterone levels are in the male range or higher. [59]

Clues to complete androgen insensitivity include a family history, sparse pubic and axillary hair, and sometimes inguinal lesions consistent with intraductal gonads. This is why, in the case of the seemingly "obvious" absence of the uterus, magnetic resonance imaging or ultrasound alone should not be used. Hormones and a karyotype are necessary, otherwise the risk of misdiagnosis remains real. [60]

The second important group of differential diagnoses are congenital obstructions to the outflow of menstrual blood, in which the uterus is present but menstruation cannot be discharged. These include transverse vaginal septum, distal vaginal atresia, and imperforate hymen. Unlike Mayer-Rokitansky-Küster-Hauser syndrome, these conditions usually have a uterus, and progressive cyclic pain, hematocolpos, or hematometra often come to the forefront. [61]

It's also important to distinguish this syndrome from gonadal dysgenesis and other endocrine causes of primary amenorrhea. In these conditions, the problem lies not in the anatomy of the Müllerian structures, but in insufficient hormonal stimulation of puberty. In these cases, normal development of secondary sexual characteristics is usually absent, and the hormonal profile and karyotype present a completely different picture. [62]

Another diagnostic pitfall is the supposed "absent uterus" in very young or severely hypoestrogenic patients. In such cases, the uterus may be small and poorly visible during the initial examination. Recent publications warn that the diagnosis of Mayer-Rokitansky-Küster-Hauser syndrome should not be made based on a single, inconclusive image without comparison with clinical features, hormones, and karyotype. A comprehensive approach protects the patient from a serious and traumatic diagnostic error. [63]

State	What does the syndrome look like?	What helps to distinguish
Complete androgen insensitivity	No uterus, short vagina, primary amenorrhea	46,XY, testosterone in the male range, sparse hair growth
Transverse septum of the vagina	Primary amenorrhea and pain	The uterus is preserved, there is outflow obstruction
Imperforate hymen	No visible menstruation, may be painful	The uterus and vagina are preserved, there is hematocolpos
Atresia of the distal vagina	Short vagina, pain	The upper sections may be preserved, the uterus is usually present
Gonadal dysgenesis	Primary amenorrhea	Insufficient sexual development, different hormonal profile
Functionally small hypoestrogenic uterus	May appear "absent" on initial examination	Repeated imaging, clinical features, hormones, karyotype

The table is based on the recommendations of the American College of Obstetricians and Gynecologists, the American Society for Reproductive Medicine, and modern analyses of the differential diagnosis of primary amenorrhea. [64]

Treatment

Treatment begins not with surgery, but with proper communication. Current guidelines emphasize that before any intervention, the patient must be given a detailed and calm explanation of the anatomy, possible forms of the syndrome, reproductive consequences, and treatment options. The psychological impact of diagnosis cannot be underestimated, and therefore, comprehensive counseling and support are considered not an addition to treatment, but an essential part of it. [65]

If the patient is not experiencing pain and sexual activity is not yet planned, immediate anatomical intervention is usually not required. Treatment should not be imposed simply because a diagnosis has been made. A modern approach is based on the patient's readiness, age, psychological state, and realistic functional goals. This strategy helps avoid a traumatic experience and increases adherence to therapy when it is truly needed. [66]

Non-surgical vaginal elongation using sequential dilation is considered the first-line method. The American College of Obstetricians and Gynecologists explicitly calls it the preferred first step because it is safer, patient-controlled, and less expensive than surgery. With good motivation and preparation, anatomical and functional success is achieved in 90-96% of patients, and modern reviews report success rates above 90% with proper technique and consistency. [67]

The most well-known variant is the Frank technique, which uses dilators gradually and regularly to create a functional vaginal canal. The success of this method depends not only on mechanical intervention but also on training, gentle supervision, addressing pain issues, and regular feedback from the specialist. It is emphasized that the duration of treatment varies greatly among patients, and some women later require maintenance dilation to prevent recurrence. [68]

If dilation is unsuccessful, the patient is unprepared for long-term self-therapy, or the anatomical situation requires a different approach, surgical creation of a neovagina is considered. Modern reviews consider surgery a second-line option. The main reason for this hierarchy is not the low effectiveness of the surgery, but rather that surgery is more invasive, requires anesthesia, often requires subsequent dilation, and carries a risk of complications. [69]

Among surgical techniques, the laparoscopic Vecchietti procedure is considered one of the most well-known. Major reviews report anatomical and functional success rates of 95-98% in large series, with high patient satisfaction. However, even this technique does require postoperative care: pain, rare vascular and visceral injuries, and the need for short-term follow-up dilation to stabilize the result are possible. [70]

Another common option is Davydov's peritoneal vaginoplasty. Its advantage lies in the use of autologous tissue and good functional results, comparable to many other procedures. However, even here, damage to the bladder or rectum, stenosis of the inlet, adhesions, and the need for additional dilation are possible. Therefore, the choice between various procedures should be made in a specialized center, rather than based on the principle of "the most well-known technique." [71]

Treatment of pain associated with functioning uterine rudiments is particularly important. If magnetic resonance imaging reveals endometrial tissue within the rudiment and the patient complains of cyclic pain, laparoscopic removal of the rudiments is considered. In a large contemporary cohort, this was one of the primary indications for surgery. This approach is aimed not at creating a vagina, but at eliminating pain and preventing complications associated with retention of menstrual fluid and endometriosis. [72]

Reproductive care is a separate treatment option. If patients retain their ovaries, they have the option of retrieving their own oocytes. For a long time, the only path to biological motherhood was assisted reproductive technology with a gestational carrier where permitted by law, and this option remains valid today. The American College of Obstetricians and Gynecologists also considers adoption and the use of a gestational carrier acceptable options. [73]

The newest and most technologically complex approach has become uterine transplantation. Following the first live birth in 2014, this method ceased to be a purely experimental idea and became a viable treatment for absolute uterine factor infertility in specialized programs. According to a 2025 review, the first 20 cases in the Dallas program resulted in 17 live births, and with a technically successful transplant viable 30 days after surgery, at least one live birth was achieved in all such cases. However, despite all the progress, uterine transplantation remains a highly specialized, resource-intensive, multi-stage procedure requiring immunosuppression and is not considered routine care for most patients. [74]

Method	Role in treatment	Advantages	Restrictions
Psychological counseling	Required for almost everyone	Helps to accept the diagnosis and choose a treatment route	It takes time and trust
Sequential dilation	First line	No surgery, high efficiency, patient controls the process	Motivation, regularity, and support are needed.
Laparoscopic Vecchietti procedure	Second line	High anatomical and functional efficiency	Invasiveness, postoperative dilation
Peritoneal vaginoplasty according to Davydov	Second line	Good results using own tissues	Risks of surgery and stenosis
Removal of painful uterine rudiments	According to the readings	Eliminates cyclic pain and reduces the risk of complications	An accurate preoperative assessment is needed
Assisted reproductive technologies with a gestational carrier	Reproductive option	The possibility of biological motherhood with one's own oocytes	Depends on legislation and availability
Uterine transplantation	Highly specialized option	Allows for pregnancy to be carried to term	Complex surgery, immunosuppression, limited availability

The table is based on the American College of Obstetricians and Gynecologists 2026 Guidelines and the 2025 Guidelines for Uterine Transplantation.[75]

Prevention

There is currently no specific prevention for Mayer-Rokitansky-Küster-Hauser syndrome. This congenital condition develops during embryogenesis, and its origin remains multifactorial and heterogeneous. Therefore, there is no proven measure that reliably prevents the disease before birth. [76]

Prevention, in a practical sense, today means not avoiding the syndrome itself, but preventing late diagnosis and complications. The most important thing is to promptly examine adolescents with primary amenorrhea and not attribute the absence of menstruation to "late puberty" if the mammary glands are already developed and the age criteria for examination have been met. The earlier the diagnosis, the easier it is to develop a gentle and psychologically safe care plan. [77]

The second level of prevention is an active search for associated anomalies. Renal and skeletal defects may not cause obvious symptoms for a long time, so once a diagnosis is established, it is important to look beyond the pelvis. This type of complication prevention is especially important in type 2, when non-genital changes may be more clinically significant than amenorrhea itself. [78]

The third component is the prevention of pain and late functional problems. In patients with cyclic pain, it is important to promptly identify functioning remnants and not delay the decision on surgery if indicated. For those undergoing dilation or surgical therapy, restenosis prevention is important through proper postoperative management and maintenance dilation as recommended by a specialist. [79]

Finally, preventing psychological trauma is crucial. This includes an accurate presentation of the diagnosis, respect for the patient's own pace, no pressure to choose surgery, and a mandatory discussion about reproductive prospects without fatalistic formulations. Current recommendations explicitly emphasize the importance of psychological counseling and contact with support groups. [80]

Forecast

The prognosis is generally favorable. Mayer-Rokitansky-Küster-Hauser syndrome itself does not shorten life expectancy, and most patients retain normal ovarian function and hormonal levels. Therefore, the primary prognosis is associated not with vital risks, but with reproductive, sexual, urological, and psychological consequences. [81]

The functional prognosis depends largely on the timeliness and quality of care. With proper primary dilation, most patients can achieve anatomical and functional results sufficient for pain-free sexual intercourse. If surgery is necessary, good results are also possible, but they are more dependent on the center's experience, method, and discipline of follow-up care. [82]

The reproductive prognosis has changed over the past 10-15 years. While previously only adoption or the use of a gestational carrier were considered where appropriate, uterine transplantation has now become an option for some patients. However, this option remains limited, and for most women, a realistic reproductive strategy still revolves around retrieving their own oocytes and transferring an embryo to a gestational carrier when legally and organizationally feasible. [83]

The prognosis for quality of life depends not only on vaginal length or the presence of surgery. It is also significantly influenced by the method of diagnosis, the quality of psychological support, the presence of partner support, the success of pain management, and the patient's confidence in reproductive prospects. This is why modern reviews consider quality of life to be a central treatment outcome, rather than a secondary psychological factor. [84]

In patients with type 2, the prognosis requires more extensive monitoring, as the long-term outcome is also determined by concomitant anomalies of the kidneys, spine, and other systems. With timely detection and multidisciplinary management, outcomes are often good, but the cost of error and late detection is higher. In other words, the overall prognosis is favorable, but it directly depends on the completeness of the initial examination and the quality of the routing. [85]

Forecasting sphere	What to expect most often
Life expectancy	Usually favorable
Hormonal function	More often saved
Sexual function after proper treatment	Can often be good
Carrying a pregnancy on your own without special technologies	Impossible
Biological motherhood	Possible using one's own oocytes and special reproductive tracts
Risk of long-term problems	Higher in type 2 and late diagnosis

The table is based on modern reviews of the syndrome and uterine transplantation. [86]

FAQ

Is Mayer-Rokitansky-Küster-Hauser syndrome a rare disease?

Yes. The most reliable prevalence estimate is around 1 in 5,000 live-born girls, although there is slight variation across samples.[87]

Why does the patient have breasts and other signs of puberty but no menstruation?

Because the ovaries usually function normally and produce estrogens, the problem is not related to a hormone deficiency, but to the absence or severe underdevelopment of the uterus and the upper part of the vagina. [88]

Can this syndrome be confused with complete androgen insensitivity?

Yes, and this is one of the most important diagnostic errors. Karyotype and testosterone levels help differentiate: in Mayer-Rokitansky-Küster-Hauser syndrome, 46,XX and a female hormonal profile are typical, while in complete androgen insensitivity, 46,XY and a male testosterone range are typical. [89]

Should all patients have surgery?

No. Non-surgical dilation is considered the first-line treatment, and in well-prepared patients, it is often sufficient. Surgery is considered if dilation is inappropriate, has failed, or the patient, for specific reasons, has chosen surgery at a specialized center. [90]

Is it possible to have your own genetically related children?

Yes, because ovarian function is often preserved, and it is possible to retrieve one's own oocytes. Practical options include the use of a gestational carrier where permitted, and in highly specialized centers, uterine transplantation. [91]

Why is it necessary to examine the kidneys and spine?

Because approximately one-third of patients have associated anomalies, the most common of which are renal and skeletal, these can be asymptomatic and therefore easily missed without a targeted search. [92]

Key points from experts

Morten Krogh Herlin, MD, PhD, is an Associate Professor in the Department of Clinical Medicine and the Division of Clinical Genetics at Aarhus University.
The main current conclusion of Morten Krogh Herlin's work is that Mayer-Rokitansky-Küster-Hauser syndrome cannot be considered as a single, simple anomaly without a genetic dimension. Modern genomic studies have identified several recurring genetic variants but have also demonstrated marked heterogeneity in the disease. This means that genetic counseling is becoming increasingly important, especially as uterine transplantation becomes more common and reproductive risks are discussed within families. [93]

Anne-Marie Amies Oelschlager, MD, professor of obstetrics and gynecology, clinician, and educator in pediatric and adolescent gynecology at the University of Washington and Seattle Children's Hospital.
The key message associated with Anne-Marie Amies Oelschlager's clinical approach and the American College of Obstetricians and Gynecologists guidelines is that primary dilation should be the first line of treatment in most patients. This approach is safer, patient-controlled, and, with good preparation, results in anatomical and functional success in 90-96% of patients. For real-world practice, this means that surgery should not be considered an automatic decision immediately after diagnosis. [94]

Mats Brännström, MD, PhD, Professor and Chief Physician of the Department of Obstetrics and Gynecology at the University of Gothenburg, is one of the pioneers of uterine transplantation.
The main thesis emerging from Mats Brännström's work is that the absolute uterine factor of infertility is no longer insurmountable. After the first live birth in 2014, uterine transplantation has become a viable, highly specialized option for some women with Mayer-Rokitansky-Küster-Hauser syndrome. However, these same data also serve as a reminder that this is a complex, multi-stage technology that is far from being widely available, requiring rigorous selection, a multidisciplinary team, and a willingness to undergo immunosuppression. [95]